Munich Reinsurance AI Stock Analysis
Munich Reinsurance (0KFE) AI Stock Analysis
Munich Reinsurance
(LSE:0KFE)
No summary available
Munich Reinsurance (0KFE) vs. iShares MSCI United Kingdom ETF (EWC)
- Market Cap
- EUR 76.79B
- Dividend Yield
- 4.23%
- Average Volume (3M)
- 64.05K
- Price to Earnings (P/E)
- 10.6
- Beta (1Y)
- 0.69
- Revenue Growth
- 0.06%
- EPS Growth
- 38.83%
- Country
- UK
- Employees
- 44,595
- Sector
- General
- Sector Strength
- 55
- Industry
- Insurance - Reinsurance
Munich Reinsurance Business Overview & Revenue Model
Company Description
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München engages in the insurance and reinsurance businesses worldwide. The company operates through six segments: Life and Health Reinsurance, Property-Casualty Reinsurance, Global Specia...
Munich Reinsurance Earnings Call Summary
The call was strongly positive overall. Munich Re reported a EUR 1.7 billion Q3 result, EUR 5.7 billion after nine months, raised full-year guidance to EUR 6.6 billion, and expects to beat full-year guidance in multiple reinsurance businesses. Operational performance, investment income, ERGO results, capital strength, and strategic growth initiatives were broadly favorable. The main challenges were lower ERGO investment returns, rising normalized P&C combined-ratio pressure, negative renewal volume trends, expected downward pricing pressure, specific disability assumption updates, and the decline in the Solvency II ratio, but these did not outweigh the positive performance described during the call.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
For full-year 2026, Munich Re raised its net result guidance to EUR 6.6 billion, with the increase coming from the reinsurance business field, and expects to exceed its annual profit target for the sixth consecutive year; life and health reinsurance remains on track for full-year guidance of EUR 1.9 billion, P&C reinsurance is expected to beat its full-year guidance after a headline actual combined ratio of 72.2% after nine months, and Global Specialty Insurance is expected to beat its full-year guidance after achieving a combined ratio below 86% for the first nine months, while ERGO International’s P&C combined ratio of 89% met full-year guidance. The group’s revenue is “now holding strong and even looks as if it may exceed those levels that we set,” the 18% outlier guidance for this year is “probably higher than it needs to be,” and normalized combined ratio upward pressure will continue in Q4, with the 11.5% discounting benefit in Q3 not considered “the new normal”; the sustainable running yield was indicated as “something more like 3.7%, with maybe potential for some upwards drift,” and the financial outlook for 2027 will be disclosed on December 10th.
Munich Reinsurance Peers Comparison
Overall Rating
DE:TLX76Outperform
DE:HNR172Outperform
DE:NBG657Neutral
DE:WUW55Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 76Outperform | EUR 33.79B | 12.96 | 25.67% | 2.75% | 2.06% | 15.31% | |
| 72Outperform | EUR 35.67B | 3.87 | 67.35% | 4.24% | 1.91% | 12.48% | |
| 57Neutral | EUR 1.42B | 31.59 | 5.09% | 1.62% | -0.95% | ― | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 55Neutral | EUR 1.24B | 9.21 | 2.73% | 4.89% | ― | ― |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| GB:0KFE | Munich Reinsurance | 587.40 | 63.47 | 12.11% | |
| DE:HNR1 | Hannover Rueck SE (UK) | 296.80 | 50.23 | 20.37% | |
| DE:TLX | Talanx AG | 132.80 | 24.36 | 22.46% | |
| DE:WUW | Wuestenrot & Wuerttembergische | 13.34 | -0.03 | -0.22% | |
| DE:NBG6 | Nuernberger Beteiligungs AG Class B | 123.50 | 5.50 | 4.66% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
